SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-007683
Filing Date
2004-03-12
Accepted
2004-03-12 15:44:05
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2130547z10-k.htm 10-K 519270
3 EXHIBIT 10.18 a2130547zex-10_18.htm EX-10.18 29014
4 EXHIBIT 14 a2130547zex-14.htm EX-14 13321
5 EXHIBIT 23.2 a2130547zex-23_2.htm EX-23.2 2288
6 EXHIBIT 31.1 a2130547zex-31_1.htm EX-31.1 5751
7 EXHIBIT 31.2 a2130547zex-31_2.htm EX-31.2 5766
8 EXHIBIT 32 a2130547zex-32.htm EX-32 4776
  Complete submission text file 0001047469-04-007683.txt   582444
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 04666065
SIC: 2836 Biological Products, (No Diagnostic Substances)